CHINA GRANTS CONDITIONAL MARKETING AUTHORIZATION FOR ITS SELF-DEVELOPED COVID-19 VACCINE

Highlights –

• China grants conditional marketing authorization for its self-developed COVID-19 vaccine.
• Beijing Biological Products Institute Co. Ltd. has developed the inactivated vaccine.
• The self-developed COVID-19 vaccine by China has shown 79.34% efficacy in its phase 3 trials.
• The vaccine is said to be provided free of charge to all Chinese people.